Raxofelast

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRaxofelast
Drug Alias Nameraxofelast雷索司特raxofelastumIRFI-016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomedica Foscama Group Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomedica Foscama
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A